Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avidan U Neumann

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Journal of Theoretical Biology|March 25, 2004
Autoimmunity as an immune defense against degenerative processes: a primary mathematical model illustrating the bright side of autoimmunityUri Nevo, Ido Golding, A U Avidan U Neumann, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2021
Considering Personalized Interferon Beta Therapy for COVID-19Karim Dorgham, Avidan U Neumann, Maxens Decavele, et al.
Bioinformatics (Oxford, England)|May 20, 2015
IMSEQ--a fast and error aware approach to immunogenetic sequence analysisLeon Kuchenbecker, Mikalai Nienen, Jochen Hecht, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 18, 2009
Early prediction of sustained virological response at day 3 of treatment with albinterferon-alpha-2b in patients with genotype 2/3 chronic hepatitis CAvidan U Neumann, Vincent G Bain, Eric M Yoshida, et al.
Iscience|July 5, 2024
Ten-year retrospective data analysis reveals frequent respiratory co-infections in hospitalized patients in AugsburgMartin Krammer, Reinhard Hoffmann, Hans-Georg Ruf, et al.
Science Translational Medicine|July 24, 2015
Comment on "Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients"Guy Gorochov, Martin Larsen, Christophe Parizot, et al.
Journal of Viral Hepatitis|September 13, 2002
Induction therapy with consensus interferon (CIFN) does not improve sustained virologic response in chronic hepatitis CThomas J Layden, Jennifer E Layden, K Rajender Reddy, et al.
Journal of Viral Hepatitis|September 13, 2002
First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral declineJennifer E Layden, Thomas J Layden, K Rajender Reddy, et al.
Hepatology (Baltimore, Md.)|June 9, 2004
Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzeesMarian E Major, Harel Dahari, Kathleen Mihalik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2003
Response to lamivudine treatment in children with chronic hepatitis B virus infectionStefan Hagmann, May Chung, Gemma Rochford, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Journal of Theoretical Biology|March 25, 2004
Autoimmunity as an immune defense against degenerative processes: a primary mathematical model illustrating the bright side of autoimmunityUri Nevo, Ido Golding, A U Avidan U Neumann, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2021
Considering Personalized Interferon Beta Therapy for COVID-19Karim Dorgham, Avidan U Neumann, Maxens Decavele, et al.
Bioinformatics (Oxford, England)|May 20, 2015
IMSEQ--a fast and error aware approach to immunogenetic sequence analysisLeon Kuchenbecker, Mikalai Nienen, Jochen Hecht, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 18, 2009
Early prediction of sustained virological response at day 3 of treatment with albinterferon-alpha-2b in patients with genotype 2/3 chronic hepatitis CAvidan U Neumann, Vincent G Bain, Eric M Yoshida, et al.
Iscience|July 5, 2024
Ten-year retrospective data analysis reveals frequent respiratory co-infections in hospitalized patients in AugsburgMartin Krammer, Reinhard Hoffmann, Hans-Georg Ruf, et al.
Science Translational Medicine|July 24, 2015
Comment on "Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients"Guy Gorochov, Martin Larsen, Christophe Parizot, et al.
Journal of Viral Hepatitis|September 13, 2002
Induction therapy with consensus interferon (CIFN) does not improve sustained virologic response in chronic hepatitis CThomas J Layden, Jennifer E Layden, K Rajender Reddy, et al.
Journal of Viral Hepatitis|September 13, 2002
First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral declineJennifer E Layden, Thomas J Layden, K Rajender Reddy, et al.
Hepatology (Baltimore, Md.)|June 9, 2004
Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzeesMarian E Major, Harel Dahari, Kathleen Mihalik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2003
Response to lamivudine treatment in children with chronic hepatitis B virus infectionStefan Hagmann, May Chung, Gemma Rochford, et al.
Pageof 9